Phase II Study of Fludarabine, Cytarabine (Ara-C), Cyclophosphamide, Cisplatin and GM-CSF (FACPGM) in Patients With Richter's Syndrome or Refractory Lymphoproliferative Disorders
暂无分享,去创建一个
M. Andreeff | H. Kantarjian | J. Cortes | A. Tsimberidou | M. Keating | S. O'brien | F. Giles | S. Faderl